The FDA has proposed cutting fees for early-stage companies conducting clinical development in the U.S. instead of abroad. | ...

Hugo is heading to the U.S., with Medtronic finally securing a stateside clearance for its robotic surgery platform. | The ...

A new CRO called Avetra has emerged with a mission of modernizing clinical research operations by prioritizing transparency ...

In 105 boys and young men enrolled in the HOPE-3 trial, patients given deramiocel every three months for a year had 54% ...

Triana Biomedicines has tapped Pfizer Ventures and a number of other existing and new investors to secure a $120 million ...

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

Swan EndoSurgical, a gastrointestinal startup launched by Olympus and Revival Healthcare Capital earlier this year, has named ...

Investigators randomized 134 people with hereditary angioedema (HAE) to receive deucrictibant or placebo. Participants took ...

Laboratoires Théa has penned a deal potentially worth up to $280 million to get its hands on Iolyx Therapeutics’ phase ...

Muvon Therapeutics has linked its cell therapy to a 60% drop in stress incontinence episode frequency in a small phase 2 ...

Mere weeks after being named the nation’s top drug regulator, Richard Pazdur, M.D., is taking steps to retire as head of the FDA’s Center for Drug Evaluation and Research at the end of this month, | ...

Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the ...